Literature DB >> 16699915

Quality of life in women with multiple sclerosis and overactive bladder syndrome.

Giuseppe Quarto1, Riccardo Autorino, Antonio Gallo, Marco De Sio, Massimo D'Armiento, Sisto Perdonà, Rocco Damiano.   

Abstract

The aim of this study was to evaluate the impact of symptoms of overactive bladder syndrome (OAB) on the quality of life (QoL) in female patients with or without multiple sclerosis (MS) and their correlation with findings from urodynamics (UDS). We enrolled 107 female patients with clinically definite MS and urinary symptoms of OAB. One-hundred female patients with similar OAB symptoms were used as a control group. Data on OAB symptoms, onset and progression, and results of any previous investigation were obtained, and any urinary complications were documented. A complete UDS investigation was performed. Health status assessment was obtained using the Kings Health Questionnaire. Results showed that urinary symptoms had a greater impact on the QoL in patients with MS. Nevertheless, the perception of the severity of these symptoms was minor in the MS group compared to the control group. No significant correlations were found between the dysfunctions as detected by UDS and the OAB symptoms in both groups. Recurrent urinary tract infections represented the main complication in the study population. In conclusion, OAB symptoms have a major impact on the QoL in patients with MS, even if their perception of QoL impairment remains limited. Optimal management in these subjects should include a complete UDS assessment.

Entities:  

Mesh:

Year:  2006        PMID: 16699915     DOI: 10.1007/s00192-006-0131-9

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  19 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

Review 2.  Natural history of multiple sclerosis.

Authors:  Orhun H Kantarci; Brian G Weinshenker
Journal:  Neurol Clin       Date:  2005-02       Impact factor: 3.806

3.  Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunction.

Authors:  M W Nortvedt; T Riise; K M Myhr; A M Landtblom; A Bakke; H I Nyland
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

4.  Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.

Authors:  Con J Kelleher; Linda Cardozo; Christopher R Chapple; Francois Haab; Arwin M Ridder
Journal:  BJU Int       Date:  2005-01       Impact factor: 5.588

Review 5.  Multiple sclerosis and the urologist.

Authors:  S E Litwiller; E M Frohman; P E Zimmern
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

6.  Urinary bladder dysfunction as a remedial disability in multiple sclerosis: a sociologic perspective.

Authors:  M Catanzaro; E J O'Shaughnessy; D C Clowers; G Brooks
Journal:  Arch Phys Med Rehabil       Date:  1982-10       Impact factor: 3.966

7.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

8.  Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis.

Authors:  E L Koldewijn; O R Hommes; W A Lemmens; F M Debruyne; P E van Kerrebroeck
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

9.  Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder.

Authors:  Pat Ray Reese; Andreas M Pleil; Gary J Okano; Con J Kelleher
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

10.  Fate of the upper urinary tract in multiple sclerosis.

Authors:  N G Kasabian; I Krause; W E Brown; Z Khan; H M Nagler
Journal:  Neurourol Urodyn       Date:  1995       Impact factor: 2.696

View more
  11 in total

1.  Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.

Authors:  Yeşim Akkoç; Murat Ersöz; Nur Yüceyar; Hakan Tunç; Kurtuluş Köklü; Tahir Kurtuluş Yoldaş; Ülkü Dönmez; Cihat Uzunköprü; Ebru Alemdaroğlu; Şule Bilen; Ufuk Emre; Şenay Özdolap; Elif Tuncay; Canan Yücesan; Haydar Gök; Merve Bahar Ercan; Kürşat Uygunol; Belgin Koçer; Murat Zinnuroğlu
Journal:  J Spinal Cord Med       Date:  2016-02-15       Impact factor: 1.985

Review 2.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

3.  Lower urinary tract symptom prevalence and management among patients with multiple sclerosis.

Authors:  Kristin M Khalaf; Karin S Coyne; Denise R Globe; Edward P Armstrong; Daniel C Malone; Jack Burks
Journal:  Int J MS Care       Date:  2015 Jan-Feb

Review 4.  A urological challenge: Voiding dysfunction in multiple sclerosis.

Authors:  Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

5.  Effects of daily tadalafil on lower urinary tract symptoms in young men with multiple sclerosis and erectile dysfunction: a pilot study.

Authors:  D Francomano; A Ilacqua; A Cortese; G Tartaglia; A Lenzi; M Inghilleri; A Aversa
Journal:  J Endocrinol Invest       Date:  2016-10-17       Impact factor: 4.256

6.  Urodynamic study and quality of life in patients with fibromyalgia and lower urinary tract symptoms.

Authors:  Maíta Poli de Araújo; Alex Carvalho Faria; Claudia Cristina Takano; Emerson de Oliveira; Marair Gracio Ferreira Sartori; Daniel Feldman Pollak; Manoel Joâo Batista Castello Girão
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-04

Review 7.  Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research.

Authors:  Ramalakshmi Ramasamy; Phillip P Smith
Journal:  Neurourol Urodyn       Date:  2021-03-14       Impact factor: 2.696

8.  Solifenacin in multiple sclerosis patients with overactive bladder: a prospective study.

Authors:  Farida van Rey; John Heesakkers
Journal:  Adv Urol       Date:  2011-05-05

9.  Usefulness of classical homeopathy for the prophylaxis of recurrent urinary tract infections in individuals with chronic neurogenic lower urinary tract dysfunction.

Authors:  Jürgen Pannek; Susanne Pannek-Rademacher; Mohinder S Jus; Jens Wöllner; Jörg Krebs
Journal:  J Spinal Cord Med       Date:  2018-02-27       Impact factor: 1.985

Review 10.  Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.

Authors:  Crisanta I Tapia; Kristin Khalaf; Karina Berenson; Denise Globe; Michael Chancellor; Lesley K Carr
Journal:  Health Qual Life Outcomes       Date:  2013-01-31       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.